A recent study found that over a third of websites selling compounded diabetes and weight loss medications, such as Ozempic and Wegovy, falsely claim they are FDA-approved.

Ozempic and other glucagon-like peptide-1 (GLP-1) agonists are a transformative new class of medicines for the treatment of ...

The remarkable efficacy of new diabetes and weight loss medicines like Ozempic and Mounjaro have been one of the biggest health stories of recent years. Despite rising rates of diabetes and obesity, ...

The weight loss injection Mounjaro is a new treatment that can now be delivered to customers' homes by a new clinic service offered by Morrisons.

Online advertising of glucagon-like peptide-1 (GLP-1) receptor agonists aimed at consumers ... Of 79 websites offering compounded versions of semaglutide, tirzepatide, or liraglutide—most with no ...

Eli Lilly and Company's impressive Q4 earnings driven by tirzepatide's success, diverse portfolio, and promising pipeline.

We found multiple active accounts advertising what purports to be semaglutide ... said they also do not allow the sale of pharmaceutical drugs on their platform. It took just minutes on the ...

WEIGHT-loss jabs are taking the world by storm, with a staggering half a million of us now using them. The injections have ...

DRIPBaR Direct' is designed to provide The DRIPBaR's clients with convenient access to personalized health and wellness solutions from the comfort of their homes. Through the VSDHOne platform, clients ...

This press release does not constitute an offer of securities for sale in the United States ... Compliant offerings include: GLP-1s (semaglutide, tirzepatide), peptides, personalized healthcare ...

Allurion’s CEO confirmed to Medical Device Network that the company has changed advertising, patient follow-up, and physician ...